1. Home
  2. EXEL vs WWD Comparison

EXEL vs WWD Comparison

Compare EXEL & WWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • WWD
  • Stock Information
  • Founded
  • EXEL 1994
  • WWD 1870
  • Country
  • EXEL United States
  • WWD United States
  • Employees
  • EXEL N/A
  • WWD N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • WWD Industrial Machinery/Components
  • Sector
  • EXEL Health Care
  • WWD Energy
  • Exchange
  • EXEL Nasdaq
  • WWD Nasdaq
  • Market Cap
  • EXEL 10.4B
  • WWD 10.8B
  • IPO Year
  • EXEL 2000
  • WWD N/A
  • Fundamental
  • Price
  • EXEL $40.35
  • WWD $239.93
  • Analyst Decision
  • EXEL Buy
  • WWD Buy
  • Analyst Count
  • EXEL 22
  • WWD 11
  • Target Price
  • EXEL $44.00
  • WWD $255.64
  • AVG Volume (30 Days)
  • EXEL 2.3M
  • WWD 503.5K
  • Earning Date
  • EXEL 10-28-2025
  • WWD 07-28-2025
  • Dividend Yield
  • EXEL N/A
  • WWD 0.47%
  • EPS Growth
  • EXEL 81.76
  • WWD 5.57
  • EPS
  • EXEL 2.08
  • WWD 6.32
  • Revenue
  • EXEL $2,230,005,000.00
  • WWD $3,426,288,000.00
  • Revenue This Year
  • EXEL $9.19
  • WWD $6.25
  • Revenue Next Year
  • EXEL $12.54
  • WWD $9.23
  • P/E Ratio
  • EXEL $19.56
  • WWD $37.74
  • Revenue Growth
  • EXEL 10.73
  • WWD 5.53
  • 52 Week Low
  • EXEL $25.17
  • WWD $146.82
  • 52 Week High
  • EXEL $49.62
  • WWD $267.45
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 61.73
  • WWD 43.69
  • Support Level
  • EXEL $38.37
  • WWD $236.09
  • Resistance Level
  • EXEL $40.78
  • WWD $244.02
  • Average True Range (ATR)
  • EXEL 1.01
  • WWD 5.08
  • MACD
  • EXEL 0.41
  • WWD -0.25
  • Stochastic Oscillator
  • EXEL 91.21
  • WWD 34.41

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About WWD Woodward Inc.

Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.

Share on Social Networks: